viral replication inhibitor (BioKorea/Pacific Pharm)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameviral replication inhibitor (BioKorea/Pacific Pharm)
Drug Alias NameHEPA-C1
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSungkyunkwan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioKorea Co LtdPacific PharmaceuticalsSungkyunkwan University
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A